Rakesh Narang

7PUBLICATIONS
6CO-AUTHORS
Biologically active moleculesHaematological tumoursCheminformatics and quantitative structure-activity relationshipsNanotoxicology, health and safetyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 13, 2026
1,3,4-Oxadiazole derivatives: targeting multiple bacterial pathways.

Pankaj Gupta, Sangeeta Verma, Rakesh Narang

|Aug 19, 2025
Tubulin inhibitors: an insight into new strategies to combat leukemia.

Sangeeta Verma, Pankaj Gupta, Rakesh Narang

|Jun 27, 2025
Quinoline Heterocyclic Clubbed Hydrazone Derivatives as Potential Inhibitors of Mutant S. aureus DNA Gyrase A; An In Silico Drug Discovery Approach -Molecular Docking, MD Simulation, DFT Analysis and ADMET Predictions.

Sangeeta Verma, Sukhbir Lal, Rakesh Narang

|Jun 27, 2024
Expanding potential of quinoline hydrazide/hydrazone derivatives as anticancer agents.

Sangeeta Verma, Sukhbir Lal, Rakesh Narang

|Jun 26, 2023
Recent insights into antibacterial potential of benzothiazole derivatives.

Priyanka Kashyap, Sangeeta Verma, Pankaj Gupta

|Jun 05, 2023
Recent Insights into Osimertinib Analogues against EGFR Positive Non-small Cell Lung Cancer.

Jatin Chhabra, Priyanka Kashyap, Rakesh Pahwa

Pageof 2

Frequent Collaborators

3 joint publications

Sangeeta Verma

3 joint publications

Sukhbir Lal

1 joint publications

Kalvatala Sudhakar

1 joint publications

Harish Dureja